Sort   by:  
 Page size 
ProteomicsLC-MSMS of the lc4 MHC class I immunopeptidome
MHC I-associated peptides (MAPs) presented at the surface of nucleated cells play a central role in CD8 T-cell immunosurveillance. MAPs presented by mature (i.e. MHC IIhi) medullary thymic epithelial cells (mTEChi) are essential to eliminate self-reactive CD8 T cells in a process called central tole...
ORGANISM(S): Homo sapiens (Human) 
2018-10-22 | PXD009754 | Pride
Human Lc-msms Immunopeptidome Lung cancer primary sample Mhc class i 
ProteomicsLC-MSMS of the lc6 MHC class I immunopeptidome
MHC I-associated peptides (MAPs) presented at the surface of nucleated cells play a central role in CD8 T-cell immunosurveillance. MAPs presented by mature (i.e. MHC IIhi) medullary thymic epithelial cells (mTEChi) are essential to eliminate self-reactive CD8 T cells in a process called central tole...
ORGANISM(S): Homo sapiens (Human) 
2018-10-22 | PXD009755 | Pride
Human Lc-msms Immunopeptidome Lung cancer primary sample Mhc class i 
ProteomicsLC-MSMS of the lc2 MHC class I immunopeptidome
MHC I-associated peptides (MAPs) presented at the surface of nucleated cells play a central role in CD8 T-cell immunosurveillance. MAPs presented by mature (i.e. MHC IIhi) medullary thymic epithelial cells (mTEChi) are essential to eliminate self-reactive CD8 T cells in a process called central tole...
ORGANISM(S): Homo sapiens (Human) 
2018-10-22 | PXD009752 | Pride
Human Lc-msms Immunopeptidome Lung cancer primary sample Mhc class i 
UnknownP923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF TREATMENT IN LOCOMMOTION AND MOMMENT FOR PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
Not available
S-EPMC10430900 | biostudies-literature
UnknownComparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma.
Not available
S-EPMC10960754 | biostudies-literature
UnknownLocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma - 2-year follow-up (final analysis).
Not available
S-EPMC11588650 | biostudies-literature
UnknownComparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Not available
S-EPMC10838813 | biostudies-literature
UnknownImmune thrombocytopenia and pregnancy: an exposed/nonexposed cohort study.
Not available
S-EPMC10644036 | biostudies-literature
UnknownAnticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Not available
S-EPMC9624238 | biostudies-literature
UnknownA dynamical measure of the black hole mass in a quasar 11 billion years ago.
Not available
S-EPMC11636685 | biostudies-literature
Sort   by:  
 Page size